Moflaxa (Moxifloxacin)

Moxifloxacin, the active ingredient in Moflaxa, is a fluoroquinolone presented as a tablet for oral use. It treats a range of bacterial infections in adults, including community‑acquired pneumonia, acute bacterial sinusitis, COPD exacerbations, skin and soft‑tissue infections, and complicated urinary tract infections.

GNH USA supplies Moflaxa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibacterial that interferes with bacterial DNA synthesis, making it effective against a variety of infections. - Community‑acquired pneumonia: eradicates causative bacteria to improve respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating pathogenic microbes. - Acute exacerbations of chronic bronchitis/COPD: controls bacterial flare‑ups and supports airway recovery. - Skin and soft‑tissue infections: clears bacterial involvement in dermal lesions. - Complicated urinary tract infections: targets resistant uropathogens to resolve infection.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertigo or light‑headedness. - Abdominal pain: cramping or discomfort. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile infection: severe colitis. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Moxifloxacin, clinicians should consider several safety aspects. - Assess renal function: adjust therapy if renal impairment is present. - Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. - Avoid in patients with known hypersensitivity to fluoroquinolones. - Use caution in individuals with QT prolongation risk or cardiac disease. - Store at room temperature: keep in the original container, protect from moisture and light.

Moxifloxacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of tendon rupture. - Other QT‑prolonging drugs: heightened chance of cardiac arrhythmias. - Antacids containing aluminum or magnesium: reduced absorption of moxifloxacin.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance central nervous system effects. - Warfarin: potential increase in anticoagulant effect. - Theophylline: possible elevation of plasma theophylline concentrations.